HAHN MARK W (Chief Financial Officer) sold 4.3% of their position (587.01K shares) of VERONA PHARMA PLC on the open market
Open‑market sale worth $5.31M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/5/2025ACC: 0001104659-25-044536
Officer· Chief Financial Officer
Since Jan 2021
-587.01K
Net shares
Net seller
$5.31M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
200K acquired · 787.01K disposed
Non-Derivative Transactions4
Ordinary Shares
Direct
Shares
−108.27K
Price / share
$8.95
Trade value
$969.06K
% of position
0.8%
5/1/2025
13.47M→13.36M
Ordinary Shares
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
1.5%
5/1/2025
13.36M→13.56M
Ordinary Shares
Direct
Shares
−78.74K
Price / share
$8.95
Trade value
$704.70K
% of position
0.6%
5/1/2025
13.56M→13.48M
Ordinary Shares
Direct
Shares
−400K
Price / share
$9.09
Trade value
$3.64M
% of position
3.0%
5/2/2025
13.48M→13.08M
Total
Net shares
−387.01K
Net value
-$5.31M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/1/2025 | S · Sale | −108.27K | $8.95 | $969.06K | 0.8% | 13.47M | 13.36M |
| Ordinary Shares Direct | 5/1/2025 | M · Option Exercise | +200K | — | — | 1.5% | 13.36M | 13.56M |
| Ordinary Shares Direct | 5/1/2025 | S · Sale | −78.74K | $8.95 | $704.70K | 0.6% | 13.56M | 13.48M |
| Ordinary Shares Direct | 5/2/2025 | S · Sale | −400K | $9.09 | $3.64M | 3.0% | 13.48M | 13.08M |
| Total | −387.01K | -$5.31M | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
200K shares
Shares
−200K
Strike price
Held after
1M
Exercisable
—
5/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares200K shares | 5/1/2025 | M · Option Exercise | −200K | — | 1M |